Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 118   

Articles published

JNJ 91.36 -1.28 (-1.38%)
price chart
Johnson & Johnson: This Dividend Aristocrat Is Attractively Priced
Johnson & Johnson (NYSE:JNJ) is a dividend aristocrat that has raised its dividend for 53 consecutive years. While its record is exceptional, its stock price has languished during the last two years, underperforming the S&P (NYSEARCA:SPY) by a wide ...
Large Inflow of Money Witnessed in Johnson & Johnson  Money Flow Index
Johnson & Johnson Price Target Update  News Watch International
Johnson & Johnson to Participate in the 2015 Morgan Stanley Healthcare Conference
NEW BRUNSWICK, N.J., Sept. 3, 2015 /PRNewswire/ -- Johnson & Johnson JNJ, -0.76% will participate in the 2015 Morgan Stanley Healthcare Conference on Thursday, Sept.
Johnson & Johnson to bring 500 jobs to Tampa
Ernie Knewitz of Johnson & Johnson said the Tampa move adds to an already significant footprint for the company in Florida.
Tampa snags Johnson & Johnson corporate services headquarters with 500 jobs
Tampa wins Johnson & Johnson shared services North American HQ  Tampa Bay Business Journal
Johnson & Johnson marks Rs 650 crore more for Telangana
HYDERABAD: Global consumer healthcare, medical devices and pharmaceuticals giant Johnson & Johnson (J&J) is looking at investing another $100 million (Rs650 crore) to more than double its annual production capacity at its upcoming India's largest ...
Johnson & Johnson goes to Silicon Valley with new hardware partnership
Johnson & Johnson JNJ 1.37% has partnered with PCH, a San Francisco hardware specialist, to help startups create innovative health care devices.
Johnson & Johnson partners with PCH to help health care startups  Silicon Valley Business Journal (blog)
Johnson & Johnson (JNJ) Stock Up on Splenda Sale
"We rate JOHNSON & JOHNSON (JNJ) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate.
Johnson & Johnson Will Sell Splenda Sweetener to Heartland Food  Bloomberg
Johnson & Johnson: The Definition Of A Great Company At A Good Price
Shares of Johnson & Johnson (NYSE:JNJ) have taken an 11% haircut this year, which has pushed its yield comfortably above 3%.
Shares of Johnson & Johnson (NYSE:JNJ) Sees Large Outflow of Money  Insider Trading Report
Johnson & Johnson Offers High Returns and Stability for a Bargain
Johnson & Johnson was founded in 1886. The company is now the largest health care business in the world. The company has a market cap of $276.7 billion, generates over $70 billion a year in sales, and $16 billion a year in profits.
8 Things You Probably Don't Know About Johnson & Johnson
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ ) is arguably the mantelpiece healthcare company all investors look up to.
Learning From Johnson & Johnson's Time In The $60s
Johnson & Johnson is an excellent example of a company that continues to provide solid business performance year-in and year-out.